导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.67% | 355/1050 |
| 近一周 | -3.42% | 968/1104 |
| 近一月 | -2.86% | 515/1103 |
| 近一季 | 0.85% | 263/1092 |
| 近半年 | 0.90% | 421/1070 |
| 近一年 | 22.30% | 226/1018 |
| 近两年 | 59.08% | 450/926 |
| 近三年 | 64.93% | 189/834 |
| 成立以来 | 139.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.04% 333/1070 |
6.15% 605/1101 |
- - |
- - |
| 2025 | 34.10% 413/1065 |
-0.65% 840/1014 |
1.74% 531/1038 |
25.12% 442/1050 |
6.03% 107/1065 |
| 2024 | 18.93% 99/1011 |
13.22% 9/960 |
4.47% 120/983 |
6.66% 833/991 |
-5.73% 712/1011 |
| 2023 | -2.26% 141/952 |
1.84% 522/880 |
-3.26% 398/895 |
2.58% 26/915 |
-3.28% 355/952 |
| 2022 | -22.71% 428/867 |
-12.12% 151/773 |
5.47% 494/806 |
-8.01% 142/845 |
-9.35% 770/867 |
| 2021 | 6.76% 278/740 |
-0.58% 174/580 |
11.25% 324/659 |
-7.17% 422/704 |
3.97% 262/740 |
| 2020 | 59.78% 198/554 |
-1.86% 211/419 |
31.12% 111/466 |
12.37% 195/517 |
10.50% 349/554 |
| 2019 | 34.92% 259/410 |
23.87% 790/1149 |
-0.61% 420/1231 |
2.96% 255/390 |
6.44% 298/410 |
| 2018 | -34.59% 266/349 |
- - |
- - |
- - |
-17.00% 952/1080 |
| 2017 | 16.57% 93/285 |
- - |
- - |
- - |
- - |
| 2016 | -26.94% 143/205 |
- - |
- - |
- - |
- - |
| 2015 | 44.78% 33/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇添富外延增长股票A VS. 东吴新产业精选股票A(580008) |